Colposcope Market: How The Market Will Perform In
Upcoming Years Based On Market Size, Share And
Demand In Major Regions | 2018-2026
Colposcopy is a diagnostic method useful for the diagnosis and evaluation of cervical
intraepithelial neoplasia and preclinical invasive cancer. It allows magnified visualization of the
site where cervical carcinogenesis occurs. Colposcope is a magnifying instrument used in the
diagnosis of cervical cancer or vaginal cancer. Colposcope can also be used to take small tissue
sections for further diagnosis via biopsy. Colposcopy is a diagnostic method usually performed
after the Pap smear test. Increasing prevalence of cervical and vaginal cancer is expected to
boost demand for colposcopy, in turn, boosting growth of the Colposcope market. Moreover,
increasing number of government initiatives such as screening programmes to increase
awareness about cancer is also expected to fuel growth of the colposcope market. Availability of
alternative methods for detection of cervical and vaginal cancer such as Pap smear test and
HPV test hinder growth of the colposcope market. The high cost of colposcope devices is also a
factor expected to hinder market growth.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1494
Colposcope Market Driver:
In several emerging economies in Africa and Asia, record high risk of cervical cancer among
women, and largely lack detection programmes and efficient screening programmes. In these
regions, governmental initiatives for cervical cancer screening and increasing healthcare
providers with skills in cervical cancer prevention are important components of global cervical
cancer control initiatives which is leading to growth of the colposcope market. According to
Centers for Disease Control and Prevention (CDC), 2014 data, 4115 women died due to cervical
cancer in the U.S. owing to the growing death rate due to cancer, governments of developed
economies are continuously focusing on increasing awareness among the populace about
screening programmes and make them accessible, to decrease the rate of mortality caused by
genital cancer. For instance, Cancer Institute NSW of Australia, state-wide government-supported